Our findings that the nervous cell-associated factor CNTN1 acts as a SARS CoV-2-specific target suggest a possible route by which the virus may interact with cells in the nervous system, which might contribute to the neurological symptoms observed in a high percentage of COVID-19 patients. Here, CNTN1 is linked to COVID-19.